Immunocore Holdings (IMCR) Retained Earnings (2019 - 2026)

Immunocore Holdings (IMCR) has reported Retained Earnings for 8 consecutive years, with $1.2 billion the latest figure, recorded in Q1 2026.

• Quarterly Retained Earnings rose 3.75% year-over-year to $1.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 billion (up 3.75% YoY) and the FY2025 annual result came in at $1.2 billion, up 4.21% from the prior year.
• Retained Earnings rose to $1.2 billion in Q1 2026 per IMCR's latest filing, from $1.2 billion in the prior quarter.
• Over the last five years, Retained Earnings for IMCR reached as high as $1.2 billion in Q1 2026 and fell as low as $396.3 million in Q4 2022.
• A 5-year average of $1.0 billion and a median of $1.2 billion in 2024 frame the typical range for Retained Earnings.
• Annual changes were most pronounced in 2023 — Retained Earnings jumped 190.12% — and 2025, when it grew 3.29%.
• Year by year, Retained Earnings stood at $396.3 million in 2022, then soared by 190.12% to $1.1 billion in 2023, then climbed by 3.52% to $1.2 billion in 2024, then grew by 4.21% to $1.2 billion in 2025, then advanced by 0.56% to $1.2 billion in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered $1.2 billion, $1.2 billion, and $1.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.